Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518463

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518463

Bioink Market - By Type (Synthetic Bioink, Natural Bioink), Material (Collagen), Application (Tissue Engineering), Printing Modality (Extrusion Based Bioprinting), End-use (Pharmaceutical and Biotechnology Companies) - Global Forecast (2024 - 2032)

PUBLISHED:
PAGES: 209 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Bioink Market size will grow at 18.1% CAGR during 2024-2032, driven by the continuous investments and focus on advancements in healthcare. For instance, WHO's Innovation in Health approach aims to foster a global movement in health innovation to accelerate the achievement of 'health for all' and the health-related Sustainable Development Goals.

As bioprinting technology advances, there is a growing trend towards using bioinks for a variety of healthcare applications. These include tissue engineering, organ regeneration, drug testing, and personalized medicine. The ability of bioinks to mimic the natural extracellular matrix and support cell growth and differentiation is crucial in developing complex tissue structures for medical purposes.

Further, the innovations in printer hardware, software, and bioink formulations that enable more precise control over the deposition of cells and biomaterials is favoring the market outlook. Improved bioprinting techniques allow researchers to create complex 3D structures with greater accuracy and fidelity to native tissues. Additionally, advancements in imaging technologies and biomaterial sciences are enhancing the biocompatibility and functionality of bioinks, expanding their applications in tissue engineering, drug testing, and disease modeling. As bioprinting technology continues to evolve, it promises to revolutionize healthcare by enabling the creation of customized tissues and organs for therapeutic and research purposes.

The bioink industry is classified based on type, material, application, printing modality, end-use, and region.

The synthetic bioink segment will gain prominence through 2032, due to its versatility and reproducibility in bioprinting applications. Synthetic bioinks offer precise control over mechanical and biochemical properties, allowing researchers to tailor formulations for specific tissue engineering requirements. The ability to engineer synthetic bioinks with tunable properties enhances their appeal across academic research, pharmaceutical development, and clinical applications, further driving their adoption.

The academic & research institutes segment will bolster the industry growth in the coming years, on account of the research that continues to uncover new potential of bioinks. As centers of innovation and experimentation, these institutions are at the forefront of developing advanced bioprinting technologies and applications. Their focus on tissue engineering, regenerative medicine, and complex 3D cell culture models necessitates the use of high-quality bioinks to replicate the intricate structures of human tissues and organs. The push for cutting-edge research to address critical medical challenges, such as organ transplantation shortages and the development of personalized medicine, further fuels the demand for bioinks.

Europe bioink industry will witness steady growth during 2024-2032, characterized by robust investments in healthcare research and biotechnology innovations. Countries like Germany, the United Kingdom, and Switzerland are leading the bioprinting research, supported by strong academic and industrial collaborations. The European Union's initiatives promoting personalized medicine and regenerative therapies further stimulate demand for bioinks capable of supporting advanced bioprinting applications. Moreover, stringent regulatory frameworks ensure high standards of biocompatibility and safety in bioink formulations, fostering trust among healthcare professionals and regulatory bodies.

Product Code: 9118

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising application in regenerative medicine
      • 3.2.1.2. Increase in demand for 3 D printed tissue and organs
      • 3.2.1.3 Rise in prevalence of chronic disease and organ failure
      • 3.2.1.4 Advancement in bioprinting technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent approval filing process
      • 3.2.2.2 High manufacturing cost
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Synthetic bioink
  • 5.3 Natural bioink

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Agarose
  • 6.3 Alginate
  • 6.4 Chitosan
  • 6.5 Collagen
  • 6.6 Gelatin
  • 6.7 Pluronic
  • 6.8 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Tissue engineering
  • 7.3 Regenerative medicine
  • 7.4 Medical applications
  • 7.5 Drug discovery & delivery
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Printing Modality, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Extrusion based bioprinting
  • 8.3 Ink-jet based bioprinting
  • 8.4 Laser-based bioprinting

Chapter 9 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pharmaceutical & biotechnology companies
  • 9.3 Hospitals & clinics
  • 9.4 Academic & research institutes
  • 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 CELLLINK
  • 11.2 BIO INK BV
  • 11.3 Advanced BioMatrix
  • 11.4 Allevi, Inc.
  • 11.5 Essent Biologics
  • 11.6 Merck KGaA
  • 11.7 Rousselot
  • 11.8 Jellagen
  • 11.9 CollPlant
  • 11.10 Foldink. Life science technology
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!